It was reported that after a tka had been performed on (b)(6) 2022 patient experienced fever, feeling of wrongness and infection.This adverse event was addressed by revision surgery on (b)(6) 2024, in which the jrny ii bcs xlpe art isrt sz 3-4 lt 9mm was exchanged to journey ii bcs insert.The jrny ii bcs femoral oxin lt sz 6, journey tibia base np lt sz 4, and gns ii biconvex pat 26mm were not explanted.Patient's current health status is unknown.
|
The devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation stated that, as it had previously been reported: ¿the surgeon doesn't think products failure.The products cannot be returned.No more information is available.¿ although infection was reported, without supporting clinical documentation a clinical root cause for the infection cannot be confirmed.The patient impact is the fever, feeling of wrongness, infection and subsequent revision.No further clinical assessment is warranted at this time.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part number of the insert, tibial baseplate and patella over the past 12 months and for their batch numbers based on historical data of the devices did not reveal similar events for the listed devices.A review of complaint history for the femoral component revealed similar events for the listed device over the previous 12 months, but no similar events for the batch based on the historical data, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for knee systems revealed that acute post-surgical wound infection has been identified in possible adverse effects.Active, local infection or previous intra-articular infections are identified in contraindications for total knee replacement.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to these products and event.A review of the sterilization records revealed the batches were sterilized within normal parameters.At this time, we have no evidence to conclude that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include loss of sterility during procedure, post-operative healing issue, injury, patient condition and/or medical history.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
|